1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Athlete's Foot (Tinea Pedis)-Pipeline Insights, 2014

SUMMARY
DelveInsight’s,“ Athlete's Foot (Tinea Pedis)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Athlete's Foot (Tinea Pedis). This report provides information on the therapeutic development based on the Athlete's Foot (Tinea Pedis) dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Athlete's Foot (Tinea Pedis)
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Athlete's Foot (Tinea Pedis) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Athlete's Foot (Tinea Pedis) and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Athlete's Foot (Tinea Pedis)
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Athlete's Foot (Tinea Pedis) pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table Of Contents

Athlete's Foot (Tinea Pedis)-Pipeline Insights, 2014
Table of Contents
- Athlete's Foot (Tinea Pedis) Overview
- Athlete's Foot (Tinea Pedis) Pipeline Therapeutics
- Athlete's Foot (Tinea Pedis) Therapeutics under Development by Companies
- Athlete's Foot (Tinea Pedis) Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Athlete's Foot (Tinea Pedis) Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Athlete's Foot (Tinea Pedis) Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Athlete's Foot (Tinea Pedis) Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Athlete's Foot (Tinea Pedis) - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Athlete's Foot (Tinea Pedis) - Discontinued Products
- Athlete's Foot (Tinea Pedis) - Dormant Products
- Companies Involved in Therapeutics Development for Athlete's Foot (Tinea Pedis)
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Athlete's Foot (Tinea Pedis), 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Athlete's Foot (Tinea Pedis) Assessment by Monotherapy Products
- Athlete's Foot (Tinea Pedis) Assessment by Combination Products
- Athlete's Foot (Tinea Pedis) Assessment by Route of Administration
- Athlete's Foot (Tinea Pedis) Assessment by Stage and Route of Administration
- Athlete's Foot (Tinea Pedis) Assessment by Molecule Type
- Athlete's Foot (Tinea Pedis) Assessment by Stage and Molecule Type
- Athlete's Foot (Tinea Pedis) Therapeutics - Discontinued Products
- Athlete's Foot (Tinea Pedis) Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Athlete's Foot (Tinea Pedis), 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Athlete's Foot (Tinea Pedis) Assessment by Monotherapy Products
- Athlete's Foot (Tinea Pedis) Assessment by Combination Products
- Athlete's Foot (Tinea Pedis) Assessment by Route of Administration
- Athlete's Foot (Tinea Pedis) Assessment by Stage and Route of Administration
- Athlete's Foot (Tinea Pedis) Assessment by Molecule Type
- Athlete's Foot (Tinea Pedis) Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Dermatophytic Onychomycosis- Market Insights, Epidemiology and Market Forecast-2023

Dermatophytic Onychomycosis- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Dermatophytic Onychomycosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Antifungal Drugs Market Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis) And Segment Forecasts, 2014 - 2025

Antifungal Drugs Market Analysis By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis) And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • November 2016
  • by Grand View Research

The global antifungal drugs market was valued at USD 10.7 billion in 2015 and is expected to reach a value of USD 12.6 billion by 2025. The increasing incidence of fungal infections worldwide is the key ...

Global Antifungal Drugs Market Analysis & Trends - Industry Forecast to 2025

Global Antifungal Drugs Market Analysis & Trends - Industry Forecast to 2025

  • $ 4200
  • Industry report
  • January 2017
  • by Accuray Research LLP

The Global Antifungal Drugs Market is poised to grow at a CAGR of around 1.8% over the next decade to reach approximately $12.8 billion by 2025. Some of the prominent trends that the market is witnessing ...


Download Unlimited Documents from Trusted Public Sources

The future of the Pain Relief Industry in the UK

  • February 2017
    5 pages
  • Pain Relief  

  • United Kingdom  

View report >

Antiseptics Markets

  • December 2016
    58 pages
  • Antiseptics  

    Anti-Infective  

View report >

Spinach Industry in the US

  • December 2016
    9 pages
  • Spinach  

    Food  

    Mineral Supplem...  

  • United States  

View report >

Otc Industry In India

9 months ago

Related Market Segments :

Antifungal

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.